Hot Pursuit     05-Apr-22
Alembic Pharmaceuticals Ltd soars 1.11%
Alembic Pharmaceuticals Ltd is quoting at Rs 764.2, up 1.11% on the day as on 12:54 IST on the NSE. The stock is down 21.44% in last one year as compared to a 22.63% gain in NIFTY and a 10.4% gain in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 764.2, up 1.11% on the day as on 12:54 IST on the NSE. The benchmark NIFTY is down around 0.26% on the day, quoting at 18006.7. The Sensex is at 60373.63, down 0.39%. Alembic Pharmaceuticals Ltd has added around 7.69% in last one month.

Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has added around 10.41% in last one month and is currently quoting at 13789.25, up 0.47% on the day. The volume in the stock stood at 1.09 lakh shares today, compared to the daily average of 2.65 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 768.3, up 1.23% on the day. Alembic Pharmaceuticals Ltd is down 21.44% in last one year as compared to a 22.63% gain in NIFTY and a 10.4% gain in the Nifty Pharma index.

The PE of the stock is 19.21 based on TTM earnings ending December 21.

Previous News
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharma's Panelav facility gets EIR from USFDA
 ( Hot Pursuit - 09-Dec-22   14:23 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
  USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
 ( Corporate News - 09-Dec-22   13:39 )
  Alembic Pharma gets USFDA nod for osteoarthritis drug
 ( Hot Pursuit - 01-Dec-22   11:44 )
  Intellect Design Arena Ltd leads losers in 'A' group
 ( Hot Pursuit - 10-May-24   15:00 )
  Alembic Pharma rises after receiving tentative approval for anti anginal drug
 ( Hot Pursuit - 20-Apr-22   11:30 )
  Alembic Pharmaceuticals rallies after receiving USFDA approval for Dabigatran Etexilate Capsules
 ( Hot Pursuit - 07-Apr-22   13:13 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 07-Apr-22   13:53 )
  Alembic Pharma Q2 PAT falls 19% YoY; R&D spend at Rs 168 crore
 ( Hot Pursuit - 11-Nov-22   14:21 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top